Evaluation of cartilage damage by measuring collagen degradation products in joint extracts in a traumatic model of osteoarthritis

Biomarkers

Volumn 13, Issue 1, 2008, Pages 79-87

  Nielsen, Rasmus H ^a   Stoop, Reinout ^b   Leeming, Diana J ^a   Stolina, Marina ^c   Qvist, Per ^a   Christiansen, Claus ^a   Karsdal, Morten A ^a  

^a NORDIC BIOSCIENCE A S   (Denmark)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c AMGEN INC   (United States)

Author keywords

Anterior cruciate ligament transaction; Cartilage damage; CTX I; CTX II; Osteoarthritis; Protein extraction

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; COLLAGEN TYPE 2; EPITOPE; GELATINASE A; GELATINASE B; HYDROXYPROLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CRUCIATE LIGAMENT; ARTICLE; CARTILAGE DEGENERATION; COLLAGEN DEGRADATION; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; OSTEOARTHRITIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RISK FACTOR; ZYMOGRAPHY;

ANIMALS; ANTERIOR CRUCIATE LIGAMENT; CARTILAGE DISEASES; CARTILAGE, ARTICULAR; COLLAGEN; COLLAGEN TYPE I; COLLAGEN TYPE II; KNEE JOINT; OSTEOARTHRITIS, KNEE; RATS;

RATTUS;

EID: 38049129316     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500701615108     Document Type: Article

References (22)

1. Amiel, D., Toyoguchi, T., Kobayashi, K., Bowden, K., Amiel, ME and Healey, RM (2003) Long-term effect of sodium hyaluronate (Hyalgan) on osteoarthritis progression in a rabbit model. Osteoarthritis & Cartilage, 11, pp. 636-643.
2. Chang, DG, Iverson, EP, Schinagl, RM, Sonoda, M., Amiel, D., Coutts, RD and Sah, RL (1997) Quantitation and localization of cartilage degeneration following the induction of osteoarthritis in the rabbit knee. Osteoarthritis & Cartilage, 5, pp. 357-372.
3. Davidson, RK, Waters, JG, Kevorkian, L., Darrah, C., Cooper, A., Donell, ST and Clark, IM (2006) Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage. Arthritis Research & Therapy, 8, p. R124.
4. Hajjaji, H El, Williams, JM, Devogelaer, JP, Lenz, ME, Thonar, EJ and Manicourt, DH (2004) Treatment with calcitonin prevents the net loss of collagen, hyaluronan and proteoglycan aggregates from cartilage in the early stages of canine experimental osteoarthritis. Osteoarthritis & Cartilage, 12, pp. 904-911.
5. Flannelly, J., Chambers, MG, Dudhia, J., Hembry, RM, Murphy, G., Mason, RM and Bayliss, MT (2002) Metalloproteinase and tissue inhibitor of metalloproteinase expression in the murine STR/ort model of osteoarthritis. Osteoarthritis & Cartilage, 10, pp. 722-733.
6. Hayami, T., Pickarski, M., Wesolowski, GA, McLane, J., Bone, A., Destefano, J., Rodan, GA and le, T Duong (2004) The role of subchondral bone remodeling in osteoarthritis: Reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis & Rheumatism, 50, pp. 1193-1206.
7. Hayami, T., Pickarski, M., Zhuo, Y., Wesolowski, GA, Rodan, GA and le, T Duong (2006) Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. Bone, 38, pp. 234-243.
8. Hoegh-Andersen, P., Tanko, LB, Andersen, TL, Lundberg, CV, Mo, JA, Heegaard, AM, Delaisse, JM and Christgau, S. (2004) Ovariectomized rats as a model of postmenopausal osteoarthritis: Validation and application. Arthritis Research & Therapy, 6, pp. R169-R180.
9. Kozaci, LD, Buttle, DJ and Hollander, AP (1997) Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures. Arthritis & Rheumatism, 40, pp. 164-174.
10. Lark, MW, Bayne, EK, Flanagan, J., Harper, CF, Hoerrner, LA, Hutchinson, NI, Singer, II, Donatelli, SA, Weidner, JR, Williams, HR, Mumford, RA and Lohmander, LS (1997) Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. Journal of Clinical Investigation, 100, pp. 93-106.
11. Oestergaard, S., Chouinard, L., Doyle, N., Karsdal, MA, Smith, SY, Qvist, P. and Tanko, LB. (2006) The utility of measuring C-terminal telopeptides of collagen type II (CTX-II) in serum and synovial fluid samples for estimation of articular cartilage status in experimental models of destructive joint diseases. Osteoarthritis & Cartilage, 14, pp. 670-679.
12. Oestergaard, S., Sondergaard, BC, Hoegh-Andersen, P., Henriksen, K., Qvist, P., Christiansen, C., Tanko, LB and Karsdal, MA (2006) Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: Implications of the time of initiation. Arthritis & Rheumatism, 54, pp. 2441-2451.
13. Parks, WC, Wilson, CL and Lopez-Boado, YS (2004) Matrix metalloproteinases as modulators of inflammation and innate immunity. Nature Review. Immunology, 4, pp. 617-629.
14. Pritzker, KP, Gay, S., Jimenez, SA, Ostergaard, K., Pelletier, JP, Revell, PA, Salter, D. and Berg, WB van den (2006) Osteoarthritis cartilage histopathology: Grading and staging. Osteoarthritis & Cartilage, 14, pp. 13-29.
15. Simon, TM and Jackson, DW (2006) Articular cartilage: Injury pathways and treatment options. Sports Medicine & Arthroscopy Review, 14, pp. 146-154.
16. Smith, GN, Mickler, EA, Albrecht, ME, Myers, SL and Brandt, KD (2002) Severity of medial meniscus damage in the canine knee after anterior cruciate ligament transection. Osteoarthritis & Cartilage, 10, pp. 321-326.
17. Sondergaard, BC, Henriksen, K., Wulf, H., Oestergaard, S., Schurigt, U., Brauer, R., Danielsen, I., Christiansen, C., Qvist, P. and Karsdal, MA (2006) Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation. Osteoarthritis & Cartilage, 14, pp. 738-748.
18. Sondergaard, BC, Wulf, H., Henriksen, K., Schaller, S., Oestergaard, S., Qvist, P., Tanko, LB, Bagger, YZ, Christiansen, C. and Karsdal, MA (2006) Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes. Osteoarthritis & Cartilage, 14, pp. 759-768.
19. Stolina, M., Adamu, S., Ominsky, M., Dwyer, D., Asuncion, F., Geng, Z., Middleton, S., Brown, H., Pretorius, J., Schett, G., Bolon, B., Feige, U., Zack, D. and Kostenuik, PJ. (2005) RANKL is a marker and mediator of local and systematic bone loss in two rat models of inflammatory arthritis. Journal of Bone and Mineral Research, 20, pp. 1756-1765.
20. Stoop, R., Buma, P., van der Kraan, PM, Hollander, AP, Billinghurst, RC, Meijers, TH, Poole, AR and Berg, WB van den (2001) Type II collagen degradation in articular cartilage fibrillation after anterior cruciate ligament transection in rats. Osteoarthritis & Cartilage, 9, pp. 308-315.
21. Tang, BL (2001) ADAMTS: A novel family of extracellular matrix proteases. International Journal of Biochemistry & Cell Biology, 33, pp. 33-44.
22. Williams, JM, Felten, DL, Peterson, RG and O'Connor, BL (1982) Effects of surgically induced instability on rat knee articular cartilage. Journal of Anatomy, 134, pp. 103-109.